glycan, and their shared endocytosis receptor have been detected in glomerulosclerosis lesions in diseased rat kid-ney [7] . In human kidney, decorin has been immunolocalAntibodies ized to areas of interstitial fibrosis, but not in glomeruli Polyclonal rabbit antisera LF-51, LF-30/136, and LF-67 [10] [11] [12] . Biglycan has been localized in glomeruli and (to human decorin, human biglycan, and human collagen collecting duct epithelial cells in developing human kidtype I, respectively) were kind gifts of Dr. Larry Fisher ney [10] . However, the distribution of biglycan in adult (National Institute of Dental Research, Bethesda, MD, human kidney has not previously been determined. A USA). LF-30/136 was generated against a synthetic pepkey role for decorin has been postulated in regulating tide corresponding to amino acids 5 to 17 of the core collagen fibrillogenesis, as demonstrated by the finding protein of human PGII/decorin, conjugated to keyhole of abnormal collagen fibrils in decorin-deficient mice limpet hemocyanin [19] . LF-51 was generated against a [13] . Both decorin and biglycan interact with collagen synthetic peptide corresponding to amino acids 11 to type I in vitro, and codeposition of these molecules has 25 of the core protein of the secreted form of human been described in various models of fibrosing injury bone PGI/biglycan, conjugated to bovine serum albumin [14, 15] .
(BSA) [19] . LF-67 was generated against 26 amino acids In this study, we examined the expression of decorin, of a synthetic C telopeptide antigen of the human collabiglycan, and collagen type I in human renal tissues demgen ␣ I (I) chain [20] . The specificities of these antisera onstrating a spectrum of glomerulopathies and tubuloinhave been previously confirmed in Western blot and terstitial fibrosis. Glomerular diseases characterized by immunoprecipitation experiments [15, [19] [20] [21] . accumulations of extracellular matrix (mesangial sclerosis) were selected to test the hypotheses (a) that decorin Immunohistochemistry and biglycan are up-regulated in glomerular sclerosing Sections were deparaffinized in xylene and rehydrated injury, and (b) that differences in extracellular matrix proin a descending ethanol series. Endogenous peroxidase teoglycan composition can be used to distinguish morwas quenched with 3% H 2 O 2 for 10 minutes. For LFphologically similar diseases.
30/136 and LF-51 staining, sections were digested with chondroitinase ABC lyase (ICN Biomedicals, Costa Mesa, CA, USA) at 250 mU/mL in 0.1 mol/L Tris, 0.01% METHODS BSA, for 60 minutes at 37ЊC, followed by blocking with Tissue selection and pathologic examination normal goat serum for 10 minutes. For collagen type I Archived paraffin-embedded diagnostic renal biopsy staining, sections were digested in proteinase K (5 g/mL tissues from cases of amyloidosis (N ϭ 18), diabetic neat 37ЊC for 15 min; Sigma, St. Louis, MO, USA). Sections phropathy (N ϭ 11), fibrillary glomerulonephritis (N ϭ 5), were incubated with primary antibody and diluted in 1% immunotactoid glomerulopathy (N ϭ 5), LCDD (N ϭ 4), BSA/phosphate-buffered saline (PBS) for one hour at nephrosclerosis (N ϭ 6), and idiopathic mesangial scleroom temperature (LF-36/130, 1:250; LF-51 and LF-67, rosis (N ϭ 4) were selected for study. All cases were 1:500), followed by a biotinylated goat antirabbit anticharacterized by light microscopy, immunofluorescence body (Vector, Burlingame, CA, USA), ABC-Elite remicroscopy, and electron microscopy, using standard agent (Vector). The reaction product was visualized with techniques [16] . Clinical and pathologic data pertaining 3,3Ј diaminobenzidine (Sigma) and nickel chloride ento the cases of immuntactoid glomerulopathy have been hancement. The slides were counterstained with methyl described in detail elsewhere [17] sues also showed focal and segmental glomerulosclerosis Formalin-fixed, paraffin-embedded tissues were deand obsolescent (globally sclerotic) glomeruli. Some gloparaffinized following standard protocol. The sections meruli showed ischemic changes consisting of wrinkling were washed with 0.5 ϫ standard sodium citrate (SSC; of glomerular basement membranes and fibrous thick-GIBCO, Grand Island, NY, USA) and digested with 5 ening of Bowman's capsules. There was variable interstig/mL proteinase K (Sigma) in Tris buffer (500 mmol/L tial fibrosis, usually accompanied by a patchy, nonspecific NaCl, 10 mmol/L Tris, pH 8.0) for 30 minutes at 37ЊC. mononuclear inflammatory cell infiltrate. Arterial vesSeveral 0.5 ϫ SSC washes were followed by prehybridsels frequently showed arteriosclerosis. Arteriolar hyaliization for two hours in 50 L of prehybridization buffer nosis and arterial amyloid deposits were identified in [50% formamide, 0.3 mol/L NaCl, 20 mmol/L Tris, pH individual cases. The severity of glomerulosclerosis, tu-8.0, 5 mmol/L ethylenediaminetetraacetic acid (EDTA), bulointerstitial fibrosis, and arteriosclerosis was rela-1 ϫ Denhardt's solution, 10% dextran sulfate, 10 mmol/L tively consistent within individual cases. dithiothreitol (DTT), 500 g/mL yeast tRNA] at 50ЊC. The hybridization was started by adding 500,000 cpm of Immunolocalization and mRNA expression of decorin 35 S-labeled riboprobe in 50 L of prehybridization buffer The results of immunohistochemical and in situ hyand was allowed to proceed overnight at 50ЊC. Sections bridization studies for decorin are summarized in Table  were then washed with 0.5 ϫ SSC, followed by RNase 1 and Figure 1 . Decorin protein and mRNA were not A (20 g/mL, 30 min at room temperature), 2 ϫ SSC identified in morphologically normal glomeruli ( A, E, and F). A distinct pattern of decorin expression 0.1 ϫ SSC/0.1% Tween 20 (Sigma) at 50ЊC, and several was evident in different glomerular diseases. Decorin 2 ϫ SSC washes. The slides were dipped in NTB2 nuclear emulsion (Kodak, Rochester, NY, USA) and exposed in localized to amyloid deposits, in glomeruli, tubulointerthe dark at 4ЊC for one to four weeks. After developing, stitium, and arterial walls (Figs. 1 B, H, and J). The sections were counterstained with hematoxylin and eosin intensity and distribution of decorin immunostaining and were dehydrated and coverslipped. Positive cellular correlated with staining for Congo Red in individual labeling was defined as five or more silver grains in a cases. Deposits of both AA and AL amyloid showed a single cell. For negative controls, simultaneous hybridsimilar reaction. No significant immunostaining for deization with the sense riboprobe was performed on replicorin was identified in mesangial areas in most cases of cate tissue sections. diabetic nephropathy, LCDD, fibrillary glomerulonephritis, immunotactoid glomerulopathy, or idiopathic RESULTS mesangial sclerosis (Fig. 1C ). Occasional glomeruli with Histologic examination features of nodular mesangial sclerosis in some cases of LCDD or diabetic nephropathy demonstrated weak, Tissues demonstrated a spectrum of histologic patterns, including normal glomerular morphology (mostly focal staining for decorin (data not shown). Decorin pro- tein accumulated in scarred glomeruli in which the uriIn the tubulointerstitial compartment, decorin accumulated in expanded zones of interstitial fibrosis (Fig. nary space was obliterated, with fibrous adhesion of the glomerular tuft to Bowman's capsule (Fig. 1D) . This 1I). The intensity of decorin immunostaining showed some variation between cases, but appeared to correlate finding was especially prominent in cases of nephrosclerosis, but was also present to a variable degree in many with the degree of tubulointerstitial fibrosis, irrespective of disease category. Decorin mRNA expression was deof the other diseased tissues examined. By in situ hybridization, decorin mRNA expression was detectable within tectable in occasional peritubular interstitial cells resembling interstitial fibroblasts or myofibroblasts (Fig. 1L ) some sclerosed glomeruli, including amyloidotic glomeruli (Fig. 1G) . [22] . Decorin mRNA-expressing cells appeared more numerous in expanded areas of interstitial fibrosis that from the intima of morphologically normal arteries and was rarely identified in the neointima of arteriosclerotic frequently showed mononuclear inflammatory cell aggregates, but the hybridization signal was not clearly vessels. Cells expressing decorin mRNA were identified in the adventitia but not in the media or intima of blood identified in mononuclear inflammatory cells or in tubular epithelial cells.
vessel walls (data not shown). Other than the association of decorin with amyloid deposits noted earlier in this In arterial vessels, decorin was localized predominantly in the adventitia (Fig. 1K) , with only focal staining article, no specific pattern of decorin immunostaining was identified in tubulointerstitium or arterial vessels in in the media, between smooth muscle cells, particularly in larger (arcuate-sized) arteries. Decorin was absent the other disease categories examined. Immunolocalization and mRNA expression of amyloidosis (Fig. 2B) , diabetic nephropathy, and of biglycan LCDD. In some of these glomeruli, biglycan staining was localized to the periphery of mesangial nodules ( (Table 1 and Fig. 2A) . No distinct in cases of fibrillary glomerulonephritis, immunotactoid pattern of biglycan expression was identified in the difglomerulopathy, or idiopathic mesangial sclerosis. Accuferent glomerular diseases examined. Mesangial areas focally showed weak staining for biglycan in some cases mulations of biglycan were identified in scarred glomer-uli in which the urinary space was obliterated, with fiIn morphologically normal kidneys, collagen type I localized to the interstitium, particularly in the medulla brous adhesion of the glomerular tuft to Bowman's capsule, in a similar distribution to that observed for (data not shown). Collagen type I accumulated in expanded zones of interstitial fibrosis (Fig. 3F ). Collagen decorin (compare Fig. 1D and Fig. 2D ). By in situ hybridization, biglycan mRNA localized to parietal epithelial type I localized to the adventitia and, focally, to the cells and, focally, to intraglomerular cells (Fig. 2E) in media of morphologically normal arteries, but was not both morphologically normal and sclerosed glomeruli. detected in normal intima. In the neointima of arterioBiglycan did not localize to peritubular or interstitial sclerotic vessels, diffuse accumulations of collagen type amyloid deposits (Fig. 2F) . The distribution of biglycan I were observed in a parallel distribution to that observed in the tubulointerstitium overlapped with that of decorin for biglycan (compare Fig. 2H and Fig. 3H ). (compare Fig. 1H and Fig. 2G) , with accentuation in vascular adventitia and diffuse staining in expanded ar-DISCUSSION eas of interstitial fibrosis. Biglycan mRNA expression
The present study is the first to our knowledge to was seen in peritubular interstitial fibroblasts or myofidescribe the synthesis and deposition of the proteoglybroblast-like cells, which were more numerous in areas cans decorin and biglycan in human glomerular diseases of interstitial fibrosis (Fig. 2J) . No hybridization signal characterized by accumulations of extracellular matrix. for biglycan was identified in tubular epithelial cells or
The demonstration of decorin and biglycan expression at in infiltrating mononuclear inflammatory cells.
sites of glomerular fibrosing injury and tubulointerstitial Biglycan peptide localized to the adventitia and, fofibrosis supports a pathogenic role for these proteoglycally, to the media of morphologically normal arteries, cans in progressive human renal disease. Differences in but was not detected in normal intima (data not shown).
proteoglycan composition may be diagnostically useful Accumulations of biglycan were diffusely present in the in distinguishing morphologically similar glomerular disneointima of arteriosclerotic vessels (Fig. 2H) . Biglycan eases. The finding that decorin colocalizes with amyloid mRNA was identified in occasional smooth muscle cells deposits, but not in diabetic nephropathy, LCDD, fibrilin the media and in neointimal cells (Fig. 2I ), but not in lary glomerulonephritis, and immunotactoid glomeruloendothelial cells.
pathy, supports the existence of different pathways of Immunolocalization of collagen type I mesangial sclerosis in these diseases, which may be related to the modulation of specific growth factors by Collagen type I protein was not identified in morphoproteoglycans. logically normal glomeruli (Table 1 and Fig. 3A) . In
The colocalization of decorin with amyloid deposits glomerular disease, collagen type I colocalized with dein glomeruli, tubulointerstitium, and arterial blood vessel corin and biglycan. Intense immunostaining for collagen walls is striking and strongly suggests a pathogenic role type I was observed in amyloid deposits, in glomeruli, for this proteoglycan in the formation of amyloid depostubular basement membranes, and artery walls, in a patits. Although there is considerable experimental evitern identical to that of decorin (Fig. 3 B, E, and G) . Collagen type I expression was similar in cases of AA dence to support a role in amyloidogenesis for basement membrane-derived extracellular matrix components, inand AL. Weak immunostaining for collagen type I was identified in mesangial nodules in some cases of LCDD cluding heparan sulfate proteoglycan, laminin, and collagen type IV [23] [24] [25] , few studies have examined the disand diabetic nephropathy that also showed staining for decorin and/or biglycan (Fig. 3C) . No immunostaining tribution of nonbasement membrane proteoglycans in amyloidotic tissues. Decorin has previously been localfor collagen type I was identified in mesangial areas in cases of fibrillary glomerulonephritis, immunotactoid ized to the periphery of A␤ amyloid deposits in the brain [26] , and both decorin and biglycan have been localized glomerulopathy, or idiopathic mesangial sclerosis. Collagen type I also colocalized with decorin and biglycan in by immunoelectron microscopy in glomerular deposits of AA [27] . The identification of decorin mRNA syntheglomeruli with features of fibrous organization of Bowman's space (compare Fig. 1D, Fig. 2D, and Fig. 3D) . sis in amyloidotic glomeruli, but not in morphologically normal glomeruli, suggests that local up-regulation of to unregulated TGF-␤ activity at these sites. Alternadecorin synthesis contributes to the accumulation of protively, binding of growth factors to extracellular matrix teoglycan in these cases. The colocalization of collagen proteoglycans may serve a reservoir function, increasing type I with amyloid has not been reported in the literathe availability of growth factors at sites of fibrosing ture. Our study raises the possibility that codeposition injury. of decorin and collagen type I may have a role in stabiliPeritubular interstitial fibroblasts expressing decorin zation and persistence of amyloid deposits.
mRNA and biglycan mRNA were more numerous in The finding of weak staining for decorin and biglycan areas of interstitial fibrosis compared with morphologiin some cases of advanced LCDD and diabetic nephropcally normal tubulointerstitium, suggesting that proteoathy was also related to the focal finding of collagen type I glycan synthesis may be up-regulated in areas of interstideposits in these tissues. Although there is experimental tial fibrosis. Biglycan mRNA, as distinct from biglycan evidence that mesangial cell synthesis of decorin is uppeptide expression, was identified in parietal epithelial regulated in hyperglycemic cell culture media [28] and cells and in occasional intraglomerular cells in both morin rodent models of diabetic glomerular disease [29] , the phologically normal and sclerotic glomeruli. The role of results of our study do not support a role for up-regulated increased biglycan synthesis in the formation of biglycan synthesis and deposition of decorin and biglycan in the accumulations in glomeruli remains undetermined. Of pathogenesis of human diabetic nephropathy, and in note, other investigators have described a somewhat difmost clinically important human glomerular diseases ferent distribution of biglycan in the kidney. In rat kidney, characterized by mesangial sclerosis. An important cabiglycan mRNA and core protein have been localized to veat is that the tissues examined in this study were obglomerular capillaries, mesangial cells, and podocytes tained from individuals with symptomatic renal disease, and in collecting ducts and distal tubules [7, 35] . In huand these investigations do not address the possibility man fetal kidney, Bianco et al have localized biglycan that decorin and biglycan may have functions in earlier protein on the surface of endothelial cells and collecting stages of glomerular injury. Further studies to examine tubules and "very occasionally" in parietal epithelial cells, the expression of these extracellular matrix molecules and they have also localized mRNA to these cells [10] . in more acute forms of glomerular injury, characterized
The results of this study, in which biglycan mRNA synby cellular proliferation and mesangiolysis, will help to thesis was not identified in endothelium or collecting define better the roles of decorin and biglycan in human ducts, suggest that biglycan expression by endothelial glomerular disease.
cells and tubular epithelial cells may be developmentally The codistribution of decorin and biglycan with collarestricted, perhaps reflecting different biologic functions gen type I in glomerulosclerosis and interstitial fibrosis in developing and mature human kidney. suggests that synthesis and/or deposition of these extraBiglycan, but not decorin, was identified in the neoincellular matrix moieties may be pathogenically related. tima of arteriosclerotic blood vessels. Distinct patterns Decorin has a key role in regulating collagen fibril assemof localization of decorin and biglycan have also been bly and growth, as demonstrated by the finding of abnordescribed in human coronary atherosclerotic plaques [15, mal collagen fibrils in decorin-deficient mice [13] , and 36], in restenosis lesions following coronary angioplasty interactions between biglycan and collagen type I have [15] , and in coronary transplant arteriopathy [31] . Based also been described in vitro [14] . The codeposition of on the demonstration of specific interactions between decorin and biglycan with collagen type I has been debiglycan and apolipoprotein E in vitro, and the immunoscribed in other instances of fibrosing injury, including histochemical colocalization of biglycan with apolipoarteriosclerotic blood vessels [15, 30, 31] , myocardial inprotein E in human coronary atherosclerotic plaques, it farction [32] , and keloids [33] . Proteoglycan-collagen has been proposed that interactions between proteoglytype I interactions may contribute to stabilization of the cans and lipoproteins may contribute to the pathogenesis remodeled extracellular matrix at sites of fibrosing inof atherosclerosis by trapping lipoproteins in the artery jury. Decorin and biglycan bound to collagen fibrils may wall [36] . The finding of distinct and overlapping patterns be sequestered from the normal pathway of reuptake of decorin and biglycan accumulation in the kidney sugand receptor-mediated endocytosis [2], thus contributing gests specific, albeit as yet undetermined pathogenic to the formation of immunohistochemically detectable roles in human renal fibrosis that may be related to deposits at sites of collagen type I deposition. This interdifferent biologic properties of these molecules. Howpretation is consistent with in vitro observations of deever, the pathogenesis of proteoglycan accumulation in layed turnover of proteoglycans synthesized by fibrofibrotic disease is complex and multifactorial, and other blasts grown on a collagenous matrix [34] . It is interesting factors not examined in this study, such as local differto speculate that binding of proteoglycans to collagen ences in activity of profibrogenic cytokines [37] and mamay lead to reduced availability of these molecules for interactions with growth factors, such as TGF-␤, leading trix degrading enzymes, are likely to be important in 
